Vericel VCEL
NASDAQ VCEL
$40.94 +0.36 (+0.89%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vericel (VCEL) EBITDA Margin (2011 - 2026)

Updated

Vericel's EBITDA Margin was 5.23% in Q2 2026, up 3.97 percentage points from 1.26% a year earlier and up 12.24 percentage points from the prior quarter.

Analysis

Vericel (VCEL) EBITDA Margin (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vericel's EBITDA Margin was 10.17% through Jun 30, 2026, up 6.35 percentage points year-over-year; for FY2025, it came in at 8.18%, up 3.95 percentage points from FY2024.

  • EBITDA Margin has now increased for three consecutive years, with a five-year change of +4.33 percentage points (FY2020 to FY2025).
  • In earlier years, EBITDA Margin was 4.23% in FY2024 (+5.15 pp), -0.93% in FY2023 (+7.03 pp), -7.96% in FY2022 (-4.83 pp) and -3.13% in FY2021 (-6.97 pp).
  • Quarterly EBITDA Margin has moved between -21.55% (Q2 2022) and 27.45% (Q4 2025) over five years.
  • Compared with a year earlier, EBITDA Margin has increased for five straight quarters, with an average year-over-year change of +4.91 percentage points over the last eight quarters.
  • The best year-over-year quarter for EBITDA Margin over five years was Q1 2026 (a gain of 12.20 percentage points); the worst was Q3 2021 (a drop of 25.02 percentage points).
  • Per Business Quant data, VCEL's EBITDA Margin in the three quarters before Q2 2026 was -7.01% (Q1 2026), 27.45% (Q4 2025) and 9.47% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 35.95%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 49.01%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.11%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 46.01%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -124.26%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 39.16%
10 Vericel 2.09 Bn 1.51 Bn 56.40 Mn 5.30%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.30%
Mar 31, 2026 -6.93%
Dec 31, 2025 27.50%
Sep 30, 2025 9.55%
Jun 30, 2025 1.35%
Mar 31, 2025 -19.11%
Dec 31, 2024 26.55%
Sep 30, 2024 -1.88%
Jun 30, 2024 -8.84%
Mar 31, 2024 -7.86%
Dec 31, 2023 21.44%
Sep 30, 2023 -8.45%
Jun 30, 2023 -10.31%
Mar 31, 2023 -16.98%
Dec 31, 2022 13.62%
Sep 30, 2022 -14.92%
Jun 30, 2022 -21.55%
Mar 31, 2022 -17.74%
Dec 31, 2021 10.31%
Sep 30, 2021 -12.35%
API Access

Vericel EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VCEL&period=max&api_key=YOUR_API_KEY